reports
PetIQ Names Camillo Pane as Chief Executive Officer
PetIQ Names Camillo Pane as Chief Executive Officer Accomplished Consumer Goods and Health Care LeaderWould Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen. Mr. Pane’s passion for making a difference in the lives of consumers has been a constant focus through...
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Gr...
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the tran...
PetIQ, Inc. Announces Results of Special Meeting of Stockholders
PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquir...
PetIQ, Inc. Reports Second Quarter 2024 Financial Results
PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ’s Founder and CEO, commented, “We are ...
PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk G...
PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk...
PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesd...
PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 EAGLE, Idaho, July 17, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the second quarter and six months ended June 30, 2024, on Wednesday, August 7, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, A...
Petiq Inc: 1 director
A director at Petiq Inc sold 12,117 shares at 22.190USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Gro...
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today announced that members of its executive management team will participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference. A virtual fireside chat will be available on Tuesday, June 11, 2024 at 10:30 a.m. EDT. The live webcast and replay is accessible on the “Investors” section of the Company’s website at...
PetIQ, Inc. Reports First Quarter 2024 Financial Results
PetIQ, Inc. Reports First Quarter 2024 Financial Results Reports Record First Quarter 2024 Net Sales of $308.4 MillionAchieves Record First Quarter Net IncomeRecord Adjusted EBITDA Exceeds Company's First Quarter 2024 GuidanceRaises Full Year 2024 Outlook EAGLE, Idaho, May 08, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the first quarter ended March 31, 2024. Cord Christensen, PetIQ’s Founder and CEO commented, “We’ve started 2024 off well with broad-based gro...
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesda...
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 EAGLE, Idaho, April 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the first quarter ended March 31, 2024, on Wednesday, May 8, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Wednesday, May 8, 2024. To partic...
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With ...
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized Dogs Minties® Products Offer Pets Fresh Breath and Help Keep Teeth Clean and Healthy EAGLE, Idaho, March 14, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product, and wellness company, has announced the launch of Minties® dental treats for large-sized dogs, expanding the Minties® brand to now include affordable, veterinarian-recommended dental treats for tiny/small, medium, and large-sized dogs, as well as cats. R...
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Intro...
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources Vet-Recommended NextStar® “Kills, Protects, Prevents” Without a Prescription; Telehealth Support Line with Real-Time, Live Veterinary Professionals Available for Pet Parents EAGLE, Idaho, March 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, has officially kicked off flea & tick season with NextStar,® the fastest-acting 30-day topical protection available,* to he...
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Result...
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 BillionAdjusted EBITDA Exceeds Company's Full Year 2023 GuidanceReports Highest Annual Cash from Operations in the Company's History of $61.9 MillionProvides First Quarter 2024 and Full Year 2024 Outlook EAGLE, Idaho, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the fourth quarter and full year ended Decemb...
PetIQ, Inc. to Report Fourth Quarter and Full Year 2023 Financial Resu...
PetIQ, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024 EAGLE, Idaho, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET ...
PetIQ, Inc.’s New SENTRY® Portable Calming Diffuser Helps Calm Dogs an...
PetIQ, Inc.’s New SENTRY® Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond Portable Calming Diffuser Uses Scientifically Proven Pheromone Technology To Help Pets Lead Happier, Less Stressful Lives EAGLE, Idaho, Dec. 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, has announced the launch of the Portable Calming Diffuser for Dogs and Cats from its SENTRY® Calming line of pet care products just in time to help pets feel calm and relaxed during the holiday season a...
PetIQ, Inc. Reports Third Quarter 2023 Financial Results
PetIQ, Inc. Reports Third Quarter 2023 Financial Results Record Third Quarter 2023 Net Sales Increase 32% to $277.0 Million Net Sales and Adjusted EBITDA Exceed Company's Third Quarter 2023 Guidance Highest Year-to-Date Cash from Operations in the Company's History of $64.7 Million Announces Services Segment Optimization Raises 2023 Annual Outlook EAGLE, Idaho, Nov. 07, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the third quarter and nine months ended September 30,...
PetIQ, Inc. to Report Third Quarter 2023 Financial Results on Tuesday,...
PetIQ, Inc. to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2023, on Tuesday, November 7, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, November 7, 2023. To pa...
PetIQ, Inc. Reports Second Quarter 2023 Financial Results
PetIQ, Inc. Reports Second Quarter 2023 Financial Results Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 Million Raises 2023 Annual Outlook EAGLE, Idaho, Aug. 08, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the second quarter and six months ended June 30, 2023. Cord Christensen, PetIQ’s Chairman & CEO commented, “We are ...
PetIQ, Inc. Appoints John Pearson to Executive Vice President, Service...
PetIQ, Inc. Appoints John Pearson to Executive Vice President, Services & Manufactured Products EAGLE, Idaho, Aug. 02, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that John Pearson, who has served as the Company’s Senior Vice President, Head of Services since 2022, has been appointed Executive Vice President, Services & Manufactured Products, a newly created role, effective August 2, 2023. In his new role, Pearson will gain responsibility for PetIQ’s manufactured product portfolio, inclusive...
PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday...
PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2023, on Tuesday, August 8, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, August 8, 2023. To participate...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.